MUMBAI, India, Dec. 13 -- Intellectual Property India has published a patent application (202511101973 A) filed by Ankita, Bilaspur, Himachal Pradesh, on Oct. 23, for 'a system and method for developing a synbiotic nanocapsule composition based on pyrus communis and ficus carica extracts for targeted gastrointestinal therapy.'
Inventor(s) include Ankita.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a system and method for developing and delivering a fruit-based synbiotic probiotic formulation derived from Pyrus communis (pear) and Ficus carica (fig) for targeted gastrointestinal therapy. The invention comprises a low-temperature bioactive extraction process that preserves prebiotic-rich compounds, a controlled fermentation module for cultivating probiotic strains, and a system for preparing and delivering a synbiotic beverage formulation or a dual-layer nanocapsule encapsulation system featuring an inner lipid-polymer matrix and an outer alginate-chitosan coating for pH-responsive intestinal release. The resulting formulation provides a non-dairy, plant-based probiotic solution that enhances microbial viability, stability, and bioavailability while delivering synergistic health benefits from fruit-derived polyphenols and fructooligosaccharides. This innovative nutraceutical system offers improved digestive balance, intestinal protection, and long-term shelf stability, providing a safe, natural, and effective therapeutic approach for promoting gastrointestinal health and managing disorders such as IBS, IBD, and colitis."
Disclaimer: Curated by HT Syndication.
